Key Dates

Related Announcements

• June 29, 2023 - Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed). See NOFO PA-23-189.

Issued by

National Cancer Institute (NCI)

Purpose

This notice is to inform applicants that NCI's due dates for PA-23-189, “Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)” have been updated. 

Effective December 1, 2024, NCI will accept applications twice a year from October 1 to December 1 and from February 1 to April 2, with funding decisions anticipated in March and in June, respectively. 

The application due dates are posted in the Table of IC-Specific Information, Requirements, and Staff Contacts (see Key Dates section) of the NOFO:

Section VII. Agency Contacts

Scientific/Research Contact(s)

See Table of IC-Specific Information, Requirements and Staff Contacts

Currently, reads:

NCI Application Receipt Dates and Notifications

The National Cancer Institute accepts applications twice a year from October 1 to December 1 and from February 1 to March 30, with funding decisions anticipated in March and in June, respectively. 

Modified to read  (in bold italics):

New due dates starting in 2025

NCI Application Receipt Dates and Notifications

The National Cancer Institute accepts applications twice a year from October 1 to December 1 and from February 1 to April 2, with funding decisions anticipated in March and in June, respectively.

All other aspects of PA-23-189 remain unchanged.

Inquiries

Please direct all inquiries to:

Please direct all inquiries to:

Email: [email protected]